secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIRA PHARMACEUTICALS, INC. (MIRA)
CIK:        0001904286
Form:       8-K
Filed at:   2023-10-25T23:59:59+00:00
Accession:  0001493152-23-038279
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MIRA Pharmaceuticals appoints Brian Daly to Board, David Vorhoff resigns
------------------------------------------------------------------------

- Brian Daly appointed to Board of Directors on October 25, 2023.
- Daly named Audit Committee Chair and Compensation Committee member.
- David Vorhoff resigned from Board on October 19, 2023, with no disagreements.
- Daly brings over 30 years of Wall Street experience; currently Managing Partner at Dalglish Investment Holdings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/0001493152-23-038279-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1904286/000149315223038279/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038279

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer